Filter Results:
(925)
Show Results For
- All HBS Web
(925)
- People (2)
- News (70)
- Research (778)
- Events (1)
- Multimedia (2)
- Faculty Publications (667)
Show Results For
- All HBS Web
(925)
- People (2)
- News (70)
- Research (778)
- Events (1)
- Multimedia (2)
- Faculty Publications (667)
- 01 Feb 2000
- News
Executives Convene to Discuss Consumer-Driven Health Care
available to their workers. The conference's agenda alternated between small breakout sessions that brought together participants from different industry areas and large group discussions where all attendees could compare notes. The... View Details
- 17 Jun 2002
- Research & Ideas
Entrepreneurship in Asia and Foreign Direct Investment
complicated organizational know-how, such as the pharmaceutical and electronics industries.) "The FDI that I'm looking at also has gone into industries in which the local entrepreneurs in these... View Details
Keywords: by Martha Lagace
- 15 Feb 2000
- Research & Ideas
The Right Connections
From genome research to e-commerce, new ventures are popping up everywhere, competing for the cash needed to turn them into successful enterprises. But when vying against others in industries where high uncertainty, long development... View Details
Keywords: by Judith A. Ross
- September 2024
- Case
Myeloma Investment Fund
By: Kyle Myers and Scott Sawaya
This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure for multiple myeloma.
The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details
The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details
Keywords: Venture Philanthropy; Biomedical Research; Investing For Impact; Innovation ＆ Entrepreneurship; Venture Capital; Science-Based Business; Philanthropy and Charitable Giving; Decision Making; Health Care and Treatment; Biotechnology Industry; Biotechnology Industry
Myers, Kyle, and Scott Sawaya. "Myeloma Investment Fund." Harvard Business School Case 625-047, September 2024.
- February 2015 (Revised November 2015)
- Supplement
Building an Integrated Biopharma Company: Crucell (B)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing Agreements In Biopharmacy; Licensing; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Entrepreneurship; Health Care and Treatment; Acquisition; Innovation and Invention; Biotechnology Industry; Biotechnology Industry
Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)
- July 2014
- Teaching Note
Vaxess Technologies, Inc.
By: John A. Quelch
- May 2013
- Supplement
Can PACIV (Puerto Rico) Serve European Customers?
This is the Spreadsheet Supplement HBS Case #808099 (PACIV). Includes Exhibit 1a, Exhibit 1b, Exhibit 1c, Exhibit 1d, Exhibit 1e, Exhibit 1f, Exhibit 5, Exhibit 6, and Exhibit 8. View Details
Keywords: Entrepreneurs; Foreign Subsidiaries; Global Business; International Business; International Entrepreneurial Finance; International Operations; Entrepreneurship; Globalization; International Finance; Operations; Finance; Pharmaceutical Industry; Pharmaceutical Industry; Puerto Rico; United Kingdom; Europe; United States
- November 2011 (Revised February 2012)
- Case
China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise
By: Vicki Sato, Christoph Jaeker and Pooja Mehta Solanki
As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the... View Details
Keywords: Globalized Firms and Management; Research; Corporate Strategy; Pharmaceutical Industry; Pharmaceutical Industry; China
Sato, Vicki, Christoph Jaeker, and Pooja Mehta Solanki. "China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise." Harvard Business School Case 612-048, November 2011. (Revised February 2012.)
- April 2010
- Teaching Note
Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics
Teaching Note for [607008]. View Details
- October 2009 (Revised July 2013)
- Case
Gilead Sciences, Inc.: Access Program
By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details
Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Biotechnology Industry; Biotechnology Industry
Rangan, V. Kasturi, and Katharine Lee. "Gilead Sciences, Inc.: Access Program." Harvard Business School Case 510-029, October 2009. (Revised July 2013.)
- March 2009
- Teaching Note
Proteus Biomedical: Making Pigs Fly (TN)
Teaching Note for [809051]. View Details
- June 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (D)
By: Sandra J. Sucher and Stacy McManus
Supplements the (A) and (B) cases. View Details
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (D)." Harvard Business School Case 603-046, June 2003. (Revised October 2004.)
- 09 Feb 2016
- First Look
February 9, 2016
challenges as it seeks to continue its growth. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/816013-PDF-ENG Harvard Business School Case 316-010 The Allergan Board Under Fire (A) In 2014, the Allergan Inc. board of directors received a surprise takeover... View Details
Keywords: Sean Silverthorne
- 08 Jul 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Co-Founders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
- 10 Aug 2020
- Research & Ideas
COVID's Surprising Toll on Careers of Women Scientists
Foundation. About the Author Rachel Layne is a writer based in the Boston area. [Image: valentinrussanov] Related Reading Restaurant Revolution: How the Industry Is Fighting to Stay Alive Who Guarantees Your Workplace Is Safe for Return?... View Details
- 12 Feb 2019
- First Look
New Research and Ideas, February 12, 2019
its 150th anniversary? Purchase this case:https://cb.hbsp.harvard.edu/cbmp/product/319046-PDF-ENG Harvard Business School Case 318-005 Dr. William Carson—Intrapreneurial Innovation in the Pharmaceutical View Details
Keywords: Dina Gerdeman
- 22 Apr 2014
- First Look
First Look: April 22
occurred in the pharmaceutical industry over the past two decades. Since 1989, a number of major pharmaceutical companies (Merck, Novartis, Pfizer, etc.) have chosen to locate... View Details
Keywords: Sean Silverthorne
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
& Co., kicked off the first plenary session with a quick overview of factors contributing to the U.S. pharmaceutical industry's success in competing in the global market. Among other ad- vantages, Gilmartin cited the U.S. government's... View Details
- 09 Jan 2007
- First Look
First Look: January 9, 2007
Communications Equipment Industry Harvard Business School Case 107-025 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=107025 Symantec vs. McAfee: Competing in the Consumer Anti-virus View Details
Keywords: Martha Lagace